Medications for Chronic Spontaneous Urticaria

2 results
  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    Dupixent treats moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD with eosinophilic phenotype, chronic spontaneous urticaria, bullous pemphigoid, and allergic fungal rhinosinusitis across adults and eligible pediatric patients.
  • xolair - omalizumab injection, solution

    (Omalizumab)
    Genentech, Inc.
    Xolair treats moderate-to-severe persistent asthma (ages 6+) with perennial allergen sensitivity, chronic rhinosinusitis with nasal polyps (adults 18+), IgE-mediated food allergy (ages 1+) to reduce accidental exposure reactions, and chronic spontaneous urticaria (ages 12+) uncontrolled by antihistamines.